1.22
-0.03(-2.40%)
Currency In USD
Address
520 Broad Street
Newark, NJ 07102
United States of America
Phone
212 658 1450
Sector
Real Estate
Industry
Real Estate - Services
Employees
28
First IPO Date
March 27, 2018
| Name | Title | Pay | Year Born |
| Mr. Howard S. Jonas | Chief Executive Officer, President, Founder & Executive Chairman | 44,000 | 1956 |
| Mr. David A. Polinsky Esq. | Chief Financial Officer | 429,653 | 1972 |
| Mr. Joshua M. Fine | Chief Operating Officer | 0 | 1982 |
| Ms. Joyce J. Mason Esq. | Corporate Secretary | 0 | 1959 |
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.